Contraception
RSSArticles
-
AMH: Marker of Ovarian Reserve and More
Serum anti-Mullerian hormone (AMH) has been well-established as an accurate marker of ovarian reserve. It is solely produced in the human ovary by the granulosa cells. -
More Promise from Olaparib in Recurrent Ovarian Cancer: The BRCA Cohort
Olaparib, a poly (ADP)-ribose polymerase (PARP) inhibitor, demonstrated substantial delay until progression when administered to women as a maintenance therapy with BRCA-mutant recurrent ovarian cancer. -
Reduced Fetal Movement, Uterine Arteries, and Stillbirth
A recent study has shown a link between abnormal uterine artery waveforms in the second trimester and reduced fetal movements later in pregnancy, as well as with stillbirth and small for gestational age. -
Progress under way on the microbicide front
-
Break down barriers to gynecologic care
-
Research eyes extending the menstrual cycle
-
Web Watch: Reach diverse audiences with appropriate facts
-
Teens often misinformed about proper condom use
-
Ask questions to assess teens’ condom knowledge
-
Treatment of Vulvar Vestibulitis with Submucous Infiltrations of Methylprednisolone and Lidocaine